Literature DB >> 11861776

Neurotoxic mechanisms by Alzheimer's disease-linked N141I mutant presenilin 2.

Yuichi Hashimoto1, Takako Niikura, Yuko Ito, Yoshiko Kita, Kenzo Terashita, Ikuo Nishimoto.   

Abstract

Although it has been established that oxidative stress mediates cytotoxicity by familial Alzheimer's disease (FAD)-linked mutants of presenilin (PS)1 and that pertussis toxin inhibits cytotoxicity by FAD-linked N141I-PS2, it has not been determined whether oxidative stress is involved in cytotoxicity by N141I-PS2 or which pertussis toxin-sensitive proteins mediate the cytotoxicity. Here we report that low expression of N141I-PS2 caused neuronal cell death, whereas low expression of wild-type PS2 did not. Cytotoxicities by low and high expression of N141I-PS2 occurred through dissimilar mechanisms: the former cytotoxicity was blocked by a cell-permeable caspase inhibitor, and the latter was not. Since both mechanisms were sensitive to a cell-permeable antioxidant, we examined potential sources of reactive oxygen species in each mechanism, and found that the caspase inhibitor-sensitive neurotoxicity by N141I-PS2 was likely through NADPH oxidase and the caspase inhibitor-resistant neurotoxicity by N141I-PS2 through xanthine oxidase. Pertussis toxin greatly suppressed both toxic mechanisms by N141I-PS2, and only Galpha(o), a neuron-enriched pertussis toxin-sensitive G protein, was involved in both mechanisms. We therefore conclude that N141I-PS2 is capable of triggering multiple neurotoxic mechanisms, which can be inhibited by the combination of clinically usable inhibitors of NADPH oxidase and xanthine oxidase. This study thus provides a novel insight into the therapeutic intervention of PS2 mutant-associated FAD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861776     DOI: 10.1124/jpet.300.3.736

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  Humanin: after the discovery.

Authors:  Takako Niikura; Tomohiro Chiba; Sadakazu Aiso; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

2.  Synaptic localization of a functional NADPH oxidase in the mouse hippocampus.

Authors:  Maria V Tejada-Simon; Faridis Serrano; Laura E Villasana; Beatriz I Kanterewicz; Gang-Yi Wu; Mark T Quinn; Eric Klann
Journal:  Mol Cell Neurosci       Date:  2005-05       Impact factor: 4.314

3.  Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin.

Authors:  Takako Niikura; Hirohisa Tajima; Yoshiko Kita
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 4.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

Review 5.  Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Authors:  Michael J Surace; Michelle L Block
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

Review 6.  Mechanism of oxidative stress in neurodegeneration.

Authors:  Sonia Gandhi; Andrey Y Abramov
Journal:  Oxid Med Cell Longev       Date:  2012-05-16       Impact factor: 6.543

7.  Presenilin 2 N141I mutation induces hyperactive immune response through the epigenetic repression of REV-ERBα.

Authors:  Hyeri Nam; Younghwan Lee; Boil Kim; Ji-Won Lee; Seohyeon Hwang; Hyun-Kyu An; Kyung Min Chung; Youngjin Park; Jihyun Hong; Kyungjin Kim; Eun-Kyoung Kim; Han Kyoung Choe; Seong-Woon Yu
Journal:  Nat Commun       Date:  2022-04-13       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.